Typ : |
Časopis |
Internetový odkaz : |
https://doi.org/10.1155/2022/1931118 |
|
Výskumné tímy : |
Paris - Clinical Pharmacy Department, University Hospital Necker-Enfants Malades |
Autori : |
Hinterlang M, Sebti M, Cotteret C, Vidal F, Neven B, Cisternino S, Schlatter J. |
Titul : |
Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease. |
Référence : |
The Scientific World Journal 2022 |
|
Úroveň dôkazu : |
|
Fyzikálna stabilita : |
|
Chemická stabilita : |
|
Iné metódy : |
|
Komentáre : |
|
Zoznam zlúčenín
Ruxolitinib
|
|
|
|
|
100 mg Jakavi® (Novartis) |
|
2-8°C |
|
60 |
|
|
|
|
|
|
100 mg Jakavi® (Novartis) |
|
22-25°C |
|
60 |
|
|
|
|
|